Recombinant Glycoprotein E of Varicella Zoster Virus Contains Glycan-Peptide Motifs That Modulate B Cell Epitopes into Discrete Immunological Signatures
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant Glycoprotein E of Varicella Zoster Virus Contains Glycan-Peptide Motifs That Modulate B Cell Epitopes into Discrete Immunological Signatures
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 4, Pages 954
Publisher
MDPI AG
Online
2019-02-22
DOI
10.3390/ijms20040954
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OUP accepted manuscript
- (2018) JOURNAL OF INFECTIOUS DISEASES
- Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans
- (2018) Nicole L. Sullivan et al. JOURNAL OF VIROLOGY
- N-glycosylation of Viral E Protein Is the Determinant for Vector Midgut Invasion by Flaviviruses
- (2018) Dan Wen et al. mBio
- Epitope-mapping of the glycoprotein from Crimean-Congo hemorrhagic fever virus using a microarray approach
- (2018) Amanda Fritzen et al. PLoS Neglected Tropical Diseases
- Th1 memory differentiates recombinant from live herpes zoster vaccines
- (2018) Myron J. Levin et al. JOURNAL OF CLINICAL INVESTIGATION
- A bite so sweet: the glycobiology interface of tick-host-pathogen interactions
- (2018) Pavlina Vechtova et al. Parasites & Vectors
- Zika Virus Encoding Nonglycosylated Envelope Protein Is Attenuated and Defective in Neuroinvasion
- (2017) Arun S. Annamalai et al. JOURNAL OF VIROLOGY
- Comparison of N - and O -linked glycosylation patterns of ebolavirus glycoproteins
- (2017) Amanda L. Collar et al. VIROLOGY
- A critical appraisal of ‘Shingrix’, a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus
- (2017) Tehmina Bharucha et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial
- (2017) Olivier Godeaux et al. Human Vaccines & Immunotherapeutics
- Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections
- (2017) Christian Risinger et al. ACS Infectious Diseases
- Global Mapping ofO-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus
- (2016) Ieva Bagdonaite et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
- (2016) Anthony L. Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family
- (2015) Leslie Revoredo et al. GLYCOBIOLOGY
- Zoster Vaccination Increases the Breadth of CD4+T Cells Responsive to Varicella Zoster Virus
- (2015) Kerry J. Laing et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
- (2015) Himal Lal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Viral O-GalNAc peptide epitopes: a novel potential target in viral envelope glycoproteins
- (2015) Sigvard Olofsson et al. REVIEWS IN MEDICAL VIROLOGY
- A Strategy for O-Glycoproteomics of Enveloped Viruses—the O-Glycoproteome of Herpes Simplex Virus Type 1
- (2015) Ieva Bagdonaite et al. PLoS Pathogens
- O-Linked Glycosylation of the Mucin Domain of the Herpes Simplex Virus Type 1-specific Glycoprotein gC-1 Is Temporally Regulated in a Seed-and-spread Manner
- (2014) Rickard Nordén et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modification of the Hepatitis B Virus Envelope Protein Glycosylation Pattern Interferes with Secretion of Viral Particles, Infectivity, and Susceptibility to Neutralizing Antibodies
- (2014) R. Julithe et al. JOURNAL OF VIROLOGY
- The GalNAc-type O-Glycoproteome of CHO Cells Characterized by the SimpleCell Strategy
- (2014) Zhang Yang et al. MOLECULAR & CELLULAR PROTEOMICS
- Diverse IgG serum response to novel glycopeptide epitopes detected within immunodominant stretches of Epstein-Barr virus glycoprotein 350/220: diagnostic potential of O-glycopeptide microarrays
- (2013) Isotta D’Arrigo et al. GLYCOCONJUGATE JOURNAL
- Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
- (2012) K. E. Schmader et al. CLINICAL INFECTIOUS DISEASES
- A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults
- (2012) Isabel Leroux-Roels et al. JOURNAL OF INFECTIOUS DISEASES
- Characterization of the Viral O-Glycopeptidome: a Novel Tool of Relevance for Vaccine Design and Serodiagnosis
- (2012) E. Clo et al. JOURNAL OF VIROLOGY
- Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family
- (2011) E. P. Bennett et al. GLYCOBIOLOGY
- Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology
- (2011) Elisabeth Thomsson et al. JOURNAL OF VIROLOGICAL METHODS
- The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
- (2011) Xun Xu et al. NATURE BIOTECHNOLOGY
- Rationalizing the development of live attenuated virus vaccines
- (2010) Adam S Lauring et al. NATURE BIOTECHNOLOGY
- Location, location, location: new insights into O-GalNAc protein glycosylation
- (2010) David J. Gill et al. TRENDS IN CELL BIOLOGY
- Universal sample preparation method for proteome analysis
- (2009) Jacek R Wiśniewski et al. NATURE METHODS
- Recent insights into the biological roles of mucin-type O-glycosylation
- (2008) E Tian et al. GLYCOCONJUGATE JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now